{"Symbol": "LLY", "AssetType": "Common Stock", "Name": "Eli Lilly and Company", "Description": "Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.", "CIK": "59478", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "PHARMACEUTICAL PREPARATIONS", "Address": "LILLY CORPORATE CTR, DROP CODE 1112, INDIANAPOLIS, IN, US", "FiscalYearEnd": "December", "LatestQuarter": "2021-09-30", "MarketCapitalization": "249383600000", "EBITDA": "9657000000", "PERatio": "34.15", "PEGRatio": "1.836", "BookValue": "8.55", "DividendPerShare": "3.29", "DividendYield": "0.0126", "EPS": "6.55", "RevenuePerShareTTM": "30.58", "ProfitMargin": "0.215", "OperatingMarginTTM": "0.295", "ReturnOnAssetsTTM": "0.111", "ReturnOnEquityTTM": "94.92", "RevenueTTM": "27758500000", "GrossProfitTTM": "19056500000", "DilutedEPSTTM": "6.55", "QuarterlyEarningsGrowthYOY": "-0.083", "QuarterlyRevenueGrowthYOY": "0.18", "AnalystTargetPrice": "271.3", "TrailingPE": "39.8", "ForwardPE": "30.3", "PriceToSalesRatioTTM": "8.98", "PriceToBookRatio": "32.21", "EVToRevenue": "9.48", "EVToEBITDA": "30.59", "Beta": "0.316", "52WeekHigh": "274.98", "52WeekLow": "139.06", "50DayMovingAverage": "243.32", "200DayMovingAverage": "223.52", "SharesOutstanding": "956592000", "DividendDate": "2021-12-10", "ExDividendDate": "2021-11-12"}